{"id":788834,"date":"2023-10-06T16:21:58","date_gmt":"2023-10-06T20:21:58","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-the-jefferies-inaugural-biotech-cns-neuro-summit\/"},"modified":"2023-10-06T16:21:58","modified_gmt":"2023-10-06T20:21:58","slug":"atai-life-sciences-to-participate-in-the-jefferies-inaugural-biotech-cns-neuro-summit","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-the-jefferies-inaugural-biotech-cns-neuro-summit\/","title":{"rendered":"atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS\/Neuro Summit"},"content":{"rendered":"
\n

NEW YORK and BERLIN, Oct. 06, 2023 (GLOBE NEWSWIRE) — atai Life Sciences<\/a>\u00a0(NASDAQ: ATAI) (\u201catai\u201d), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the Jefferies Inaugural Biotech CNS\/Neuro Summit being held from October 11-12, 2023.<\/p>\n

Details of the company\u2019s participation is as follows:<\/p>\n

\n Jefferies Inaugural Biotech CNS\/Neuro Summit <\/strong>\n <\/p>\n

Format: Fireside Chat<\/p>\n

Date and Time: Wednesday, October 11th<\/sup> at 8:30 A.M. ET<\/p>\n

Location: New York, NY<\/p>\n

A webcast of the company\u2019s fireside chat will be available on atai\u2019s website under Events on the Investors section of the atai website: https:\/\/ir.atai.life\/news-events\/events\/<\/a>. A replay will be available following the live event.<\/p>\n

\n About atai Life Sciences<\/strong><\/p>\n

atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders and was founded as a response to the significant unmet need and lack of innovation in the mental health treatment landscape. atai is dedicated to efficiently developing innovative therapeutics to treat depression, anxiety, addiction, and other mental health disorders.<\/p>\n

By pooling resources and best practices, atai aims to responsibly accelerate the development of new medicines to achieve clinically meaningful and sustained behavioral change in mental health patients.<\/p>\n

atai’s vision is to heal mental health disorders so that everyone, everywhere can live a more fulfilled life. For more information, please visit\u00a0www.atai.life<\/a>.<\/p>\n

\n Contact Information<\/strong>
\n
\n Investor Contact:<\/em>
\n
\n IR@atai.life<\/a>\n <\/p>\n

\n Media Contact:<\/em>
\n
\n PR@atai.life<\/a>\n <\/p>\n

\n
\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK and BERLIN, Oct. 06, 2023 (GLOBE NEWSWIRE) — atai Life Sciences\u00a0(NASDAQ: ATAI) (\u201catai\u201d), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the Jefferies Inaugural Biotech CNS\/Neuro Summit being held from October 11-12, 2023. Details of the company\u2019s participation is as follows: Jefferies Inaugural Biotech CNS\/Neuro Summit Format: Fireside Chat Date and Time: Wednesday, October 11th at 8:30 A.M. ET Location: New York, NY A webcast of the company\u2019s fireside chat will be available on atai\u2019s website under Events on the Investors section of the atai website: https:\/\/ir.atai.life\/news-events\/events\/. A replay will be available following the live event. About atai Life Sciences atai is a clinical-stage biopharmaceutical company aiming to transform the … <\/p>\n

Continue reading “atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS\/Neuro Summit”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-788834","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\natai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS\/Neuro Summit - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-the-jefferies-inaugural-biotech-cns-neuro-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS\/Neuro Summit - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK and BERLIN, Oct. 06, 2023 (GLOBE NEWSWIRE) — atai Life Sciences\u00a0(NASDAQ: ATAI) (\u201catai\u201d), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the Jefferies Inaugural Biotech CNS\/Neuro Summit being held from October 11-12, 2023. Details of the company\u2019s participation is as follows: Jefferies Inaugural Biotech CNS\/Neuro Summit Format: Fireside Chat Date and Time: Wednesday, October 11th at 8:30 A.M. ET Location: New York, NY A webcast of the company\u2019s fireside chat will be available on atai\u2019s website under Events on the Investors section of the atai website: https:\/\/ir.atai.life\/news-events\/events\/. A replay will be available following the live event. About atai Life Sciences atai is a clinical-stage biopharmaceutical company aiming to transform the … Continue reading "atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS\/Neuro Summit"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-the-jefferies-inaugural-biotech-cns-neuro-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-06T20:21:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0NTIyMSM1ODYxNTAwIzIyMDY1ODk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-the-jefferies-inaugural-biotech-cns-neuro-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-the-jefferies-inaugural-biotech-cns-neuro-summit\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS\\\/Neuro Summit\",\"datePublished\":\"2023-10-06T20:21:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-the-jefferies-inaugural-biotech-cns-neuro-summit\\\/\"},\"wordCount\":251,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-the-jefferies-inaugural-biotech-cns-neuro-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODk0NTIyMSM1ODYxNTAwIzIyMDY1ODk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-the-jefferies-inaugural-biotech-cns-neuro-summit\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-the-jefferies-inaugural-biotech-cns-neuro-summit\\\/\",\"name\":\"atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS\\\/Neuro Summit - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-the-jefferies-inaugural-biotech-cns-neuro-summit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-the-jefferies-inaugural-biotech-cns-neuro-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODk0NTIyMSM1ODYxNTAwIzIyMDY1ODk=\",\"datePublished\":\"2023-10-06T20:21:58+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-the-jefferies-inaugural-biotech-cns-neuro-summit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-the-jefferies-inaugural-biotech-cns-neuro-summit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-the-jefferies-inaugural-biotech-cns-neuro-summit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODk0NTIyMSM1ODYxNTAwIzIyMDY1ODk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODk0NTIyMSM1ODYxNTAwIzIyMDY1ODk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/atai-life-sciences-to-participate-in-the-jefferies-inaugural-biotech-cns-neuro-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS\\\/Neuro Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS\/Neuro Summit - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-the-jefferies-inaugural-biotech-cns-neuro-summit\/","og_locale":"en_US","og_type":"article","og_title":"atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS\/Neuro Summit - Market Newsdesk","og_description":"NEW YORK and BERLIN, Oct. 06, 2023 (GLOBE NEWSWIRE) — atai Life Sciences\u00a0(NASDAQ: ATAI) (\u201catai\u201d), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the Jefferies Inaugural Biotech CNS\/Neuro Summit being held from October 11-12, 2023. Details of the company\u2019s participation is as follows: Jefferies Inaugural Biotech CNS\/Neuro Summit Format: Fireside Chat Date and Time: Wednesday, October 11th at 8:30 A.M. ET Location: New York, NY A webcast of the company\u2019s fireside chat will be available on atai\u2019s website under Events on the Investors section of the atai website: https:\/\/ir.atai.life\/news-events\/events\/. A replay will be available following the live event. About atai Life Sciences atai is a clinical-stage biopharmaceutical company aiming to transform the … Continue reading \"atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS\/Neuro Summit\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-the-jefferies-inaugural-biotech-cns-neuro-summit\/","og_site_name":"Market Newsdesk","article_published_time":"2023-10-06T20:21:58+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0NTIyMSM1ODYxNTAwIzIyMDY1ODk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-the-jefferies-inaugural-biotech-cns-neuro-summit\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-the-jefferies-inaugural-biotech-cns-neuro-summit\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS\/Neuro Summit","datePublished":"2023-10-06T20:21:58+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-the-jefferies-inaugural-biotech-cns-neuro-summit\/"},"wordCount":251,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-the-jefferies-inaugural-biotech-cns-neuro-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0NTIyMSM1ODYxNTAwIzIyMDY1ODk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-the-jefferies-inaugural-biotech-cns-neuro-summit\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-the-jefferies-inaugural-biotech-cns-neuro-summit\/","name":"atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS\/Neuro Summit - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-the-jefferies-inaugural-biotech-cns-neuro-summit\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-the-jefferies-inaugural-biotech-cns-neuro-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0NTIyMSM1ODYxNTAwIzIyMDY1ODk=","datePublished":"2023-10-06T20:21:58+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-the-jefferies-inaugural-biotech-cns-neuro-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-the-jefferies-inaugural-biotech-cns-neuro-summit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-the-jefferies-inaugural-biotech-cns-neuro-summit\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0NTIyMSM1ODYxNTAwIzIyMDY1ODk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0NTIyMSM1ODYxNTAwIzIyMDY1ODk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/atai-life-sciences-to-participate-in-the-jefferies-inaugural-biotech-cns-neuro-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS\/Neuro Summit"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/788834","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=788834"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/788834\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=788834"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=788834"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=788834"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}